You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: June 2, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Neramexane

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Neramexane?

Neramexane is an investigational drug.

There have been 16 clinical trials for Neramexane. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2008.

The most common disease conditions in clinical trials are Tinnitus, Nystagmus, Pathologic, and Nystagmus, Congenital. The leading clinical trial sponsors are Merz Pharmaceuticals GmbH, Forest Laboratories, and [disabled in preview].

Recent Clinical Trials for Neramexane
A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male SubjectsMerz Pharmaceuticals GmbHPhase 1
Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification RegimenMerz Pharmaceuticals GmbHPhase 1
Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective TinnitusMerz Pharmaceuticals GmbHPhase 3

See all Neramexane clinical trials

Clinical Trial Summary for Neramexane

Top disease conditions for Neramexane
Top clinical trial sponsors for Neramexane

See all Neramexane clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.